A positive hepatitis B core antibody (HBcAb) means you've been exposed to the hepatitis B virus at some point, either recently or in the past. This result alone doesn't confirm current infection or immunity-it's a marker of exposure, not disease status.
HBcAb appears in the blood after initial infection with hepatitis B virus (HBV). It develops during the acute phase and persists for life, even after recovery. Unlike hepatitis B surface antibody (HBsAb), which indicates protective immunity, HBcAb signals that the immune system has encountered the virus's core protein.
Testing for HBcAb is part of standard hepatitis B serology panels. It's often ordered alongside hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (HBsAb) to determine infection stage and immunity status. A positive HBcAb with negative HBsAg and positive HBsAb indicates resolved infection and immunity. A positive HBcAb with positive HBsAg suggests chronic infection.
When the hepatitis B virus enters the body, the immune system produces antibodies against its components. The core protein is one of the most immunogenic parts of the virus. Antibodies targeting this protein-called anti-HBc-are detectable within 1 to 2 months after infection.
HBcAb is typically measured using enzyme immunoassay (EIA) or chemiluminescent immunoassay (CLIA). These tests detect IgG and IgM subtypes. IgM HBcAb appears early in acute infection and usually disappears within 6 months. Persistent IgM may suggest ongoing or reactivated infection.
For example, a patient with acute hepatitis B may show: HBsAg (+), HBcAb IgM (+), HBsAb (-). After recovery, HBsAg becomes negative, HBcAb remains positive, and HBsAb turns positive. This pattern confirms past infection and immunity.
HBcAb is an immunoglobulin G (IgG) antibody produced by plasma cells in response to the hepatitis B core antigen (HBcAg). HBcAg is not detectable in serum because it's intracellular and not released into the bloodstream. Instead, the immune system targets the core protein fragments during viral clearance.
There are two forms of HBcAb:
Most labs report HBcAb as positive or negative. Some differentiate between IgM and IgG, especially in clinical settings where acute infection is suspected. A positive IgM HBcAb with negative HBsAg is rare and may indicate false positivity or very early infection.
Clinical laboratories use HBcAb testing to assess hepatitis B status in patients undergoing screening, vaccination evaluation, or pre-transplant assessment. It's required for blood donation eligibility and is part of routine prenatal screening in many countries.
The Centers for Disease Control and Prevention (CDC) recommends HBV testing for all adults aged 18 and older at least once in their lifetime. HBcAb is included in the panel to identify individuals who were infected but cleared the virus spontaneously.
For example, a 35-year-old woman with no symptoms undergoes routine health screening. Her results show: HBsAg (-), HBsAb (+), HBcAb (+). This profile indicates she was infected in the past but recovered and is now immune. She does not need the hepatitis B vaccine.
Many people mistake a positive HBcAb as evidence of active disease. That's incorrect. A positive HBcAb only confirms exposure. It does not mean you have hepatitis B now-or that you're infectious.
Another common error is assuming HBcAb equals immunity. It does not. Immunity requires the presence of hepatitis B surface antibody (HBsAb). A person can have HBcAb positive and HBsAb negative-indicating past infection without protection.
Some labs report "total" HBcAb, which includes both IgM and IgG. This can lead to confusion if IgM is not specified. Always request the subtype if acute infection is suspected.
HBcAb cannot be used to diagnose chronic hepatitis B. Only HBsAg positivity confirms chronic infection. A positive HBcAb with negative HBsAg is consistent with resolved infection.
Understanding the difference between HBcAb and other hepatitis B markers is essential for accurate interpretation.
| Marker | Indicates | Positive Result Means |
|---|---|---|
| HBsAg | Active viral infection | Current HBV infection (acute or chronic) |
| HBsAb | Protective immunity | Immunity from vaccination or past recovery |
| HBcAb | Past or current exposure | History of infection, not immunity |
For example, a healthcare worker with a positive HBcAb and negative HBsAg is not currently infected. But they lack protective immunity and should receive the hepatitis B vaccine series to prevent future infection.
A 28-year-old man gets a pre-employment physical. His lab results show:
This combination-positive HBsAb and HBcAb, negative HBsAg-indicates he had a past hepatitis B infection that his body cleared. He is immune and does not need the vaccine. He is not contagious.
Conversely, a patient with HBsAg (+), HBcAb (+), HBsAb (-) has chronic hepatitis B. They require monitoring and possible treatment. HBcAb is positive here too, but the presence of HBsAg overrides it.
In my work reviewing serology reports, I once saw a college student with a positive HBcAb and negative HBsAg. He was anxious, thinking he had a chronic illness. After confirming HBsAb was positive, we explained that he had recovered from a mild childhood infection and was protected. He didn't need treatment, but he did need education to reduce stigma.
That moment highlighted how critical context is. A single test result without the full picture leads to unnecessary worry.
If your test shows a positive hepatitis B core antibody, consult a healthcare provider to interpret the full panel. Do not assume immunity or disease based on this result alone.
Check for hepatitis B surface antibody (HBsAb). If HBsAb is negative, you are not immune and should get vaccinated. If HBsAb is positive, you are protected.
For those with chronic infection (HBsAg positive), refer to a hepatologist or infectious disease specialist. The American Association for the Study of Liver Diseases (AASLD) guidelines recommend regular liver function tests and ultrasound monitoring for chronic carriers.
For travelers, donors, or healthcare workers, a positive HBcAb with negative HBsAg may affect eligibility. Check local regulations. Some blood banks exclude donors with positive HBcAb even if HBsAg is negative.
A positive hepatitis B core antibody is not a diagnosis-it's a clue. With the right follow-up, it leads to clarity, not fear.